相似文献
1
Localization of a gene (MCUL1) for multiple cutaneous leiomyomata and uterine fibroids to chromosome 1q42.3-q43.
Am J Hum Genet. 2001 May;68(5):1264-9. doi: 10.1086/320124. Epub 2001 Mar 14.
2
Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer.
Nat Genet. 2002 Apr;30(4):406-10. doi: 10.1038/ng849. Epub 2002 Feb 25.
3
A genome-wide screen and linkage mapping for a large pedigree with episodic ataxia.
Neurology. 2005 Jul 12;65(1):156-8. doi: 10.1212/01.wnl.0000167186.05465.7c.
4
The autosomal recessive Kenny-Caffey syndrome locus maps to chromosome 1q42-q43.
Genomics. 1998 Nov 15;54(1):13-8. doi: 10.1006/geno.1998.5530.
5
Genomewide linkage scan for split-hand/foot malformation with long-bone deficiency in a large Arab family identifies two novel susceptibility loci on chromosomes 1q42.2-q43 and 6q14.1.
Am J Hum Genet. 2007 Jan;80(1):105-11. doi: 10.1086/510724. Epub 2006 Nov 29.
6
Multiple cutaneous and uterine leiomyomas: refinement of the genetic locus for multiple cutaneous and uterine leiomyomas on chromosome 1q42.3-43.
J Invest Dermatol. 2002 May;118(5):876-80. doi: 10.1046/j.1523-1747.2002.01741.x.
7
Multiple hits for the association of uterine fibroids on human chromosome 1q43.
PLoS One. 2013;8(3):e58399. doi: 10.1371/journal.pone.0058399. Epub 2013 Mar 14.
8
Genetic heterogeneity among uterine leiomyomata: insights into malignant progression.
Hum Mol Genet. 2007 Apr 15;16 Spec No 1:R7-13. doi: 10.1093/hmg/ddm043.
9
[Familial occurrence of a type 2 segmental manifestation of cutaneous leiomyomatosis].
J Dtsch Dermatol Ges. 2005 Sep;3(9):695-9. doi: 10.1111/j.1610-0387.2005.05742.x.
10
Multiple cutaneous and uterine leiomyomata resulting from missense mutations in the fumarate hydratase gene.
Clin Exp Dermatol. 2006 Jan;31(1):118-21. doi: 10.1111/j.1365-2230.2005.01977.x.
引用本文的文献
1
Timely recognition of a probably life-threatening genodermatosis: familial case report of hereditary leiomyomatosis and renal cell cancer.
Pathol Oncol Res. 2025 Apr 8;31:1612086. doi: 10.3389/pore.2025.1612086. eCollection 2025.
2
Advances in Molecular Mechanisms of Kidney Disease: Integrating Renal Tumorigenesis of Hereditary Cancer Syndrome.
Int J Mol Sci. 2024 Aug 21;25(16):9060. doi: 10.3390/ijms25169060.
3
Genetic Alterations in Benign Adrenal Tumors.
Biomedicines. 2022 Apr 30;10(5):1041. doi: 10.3390/biomedicines10051041.
4
Complete Response of Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC)-Associated Renal Cell Carcinoma to Pembrolizumab Immunotherapy: A Case Report.
Front Oncol. 2021 Oct 15;11:735077. doi: 10.3389/fonc.2021.735077. eCollection 2021.
5
[Clinicopathological features and prognosis of fumarate hydratase deficient renal cell carcinoma].
Beijing Da Xue Xue Bao Yi Xue Ban. 2021 Aug 18;53(4):640-646. doi: 10.19723/j.issn.1671-167X.2021.04.003.
6
Molecular Genetic and Genomic Alterations in Cushing's Syndrome and Primary Aldosteronism.
Front Endocrinol (Lausanne). 2021 Mar 12;12:632543. doi: 10.3389/fendo.2021.632543. eCollection 2021.
7
Hereditary leiomyomatosis and renal cell cancer syndrome - case report and review of the literature.
Rom J Morphol Embryol. 2020 Apr-Jun;61(2):569-575. doi: 10.47162/RJME.61.2.29.
8
Complete response of hereditary leiomyomatosis and renal cell cancer (HLRCC)-associated renal cell carcinoma to nivolumab and ipilimumab combination immunotherapy by: a case report.
Fam Cancer. 2021 Jan;20(1):75-80. doi: 10.1007/s10689-020-00195-0. Epub 2020 Jul 15.
9
Adrenocortical tumorigenesis: Lessons from genetics.
Best Pract Res Clin Endocrinol Metab. 2020 May;34(3):101428. doi: 10.1016/j.beem.2020.101428. Epub 2020 May 23.
10
Advances in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) research.
Semin Cancer Biol. 2020 Apr;61:158-166. doi: 10.1016/j.semcancer.2019.10.016. Epub 2019 Nov 2.
本文引用的文献
1
MULTIPLE CUTANEOUS LEIOMYOMA IN IDENTICAL TWINS.
Arch Dermatol. 1964 Jul;90:81-2. doi: 10.1001/archderm.1964.01600010087018.
2
Heritability and risk factors of uterine fibroids--the Finnish Twin Cohort study.
Maturitas. 2000 Nov 30;37(1):15-26. doi: 10.1016/s0378-5122(00)00160-2.
3
Misexpression of wild-type and truncated isoforms of the high-mobility group I proteins HMGI-C and HMGI(Y) in uterine leiomyomas.
Am J Pathol. 1999 Nov;155(5):1535-42. doi: 10.1016/S0002-9440(10)65469-7.
4
Deletion 7q in uterine leiomyoma: fluorescence in situ hybridization characterization on primary cytogenetic preparations.
Cancer Genet Cytogenet. 1999 Sep;113(2):183-7. doi: 10.1016/s0165-4608(99)00025-4.
5
Deletion of HMG17 in uterine leiomyomas with ring chromosome 1.
Cancer Genet Cytogenet. 1999 Jan 15;108(2):107-9. doi: 10.1016/s0165-4608(98)00128-9.
6
Allelotype analysis of uterine leiomyoma: localization of a potential tumor suppressor gene to a 4-cM region of chromosome 7q.
Mol Carcinog. 1998 Dec;23(4):243-7. doi: 10.1002/(sici)1098-2744(199812)23:4<243::aid-mc7>3.0.co;2-e.
7
Genes control the cessation of a woman's reproductive life: a twin study of hysterectomy and age at menopause.
J Clin Endocrinol Metab. 1998 Jun;83(6):1875-80. doi: 10.1210/jcem.83.6.4890.
8
Molecular analysis of chromosome 7q21.3 in uterine leiomyoma: analysis using markers with linkage to insulin resistance.
Cancer Genet Cytogenet. 1998 Jan 15;100(2):165-8. doi: 10.1016/s0165-4608(97)00032-0.
9
Rearrangements of the high mobility group protein family genes and the molecular genetic origin of uterine leiomyomas and endometrial polyps.
Mol Hum Reprod. 1996 Apr;2(4):277-83. doi: 10.1093/molehr/2.4.277.
10
Two discrete regions of deletion at 7q in uterine leiomyomas.
Genes Chromosomes Cancer. 1997 Jul;19(3):156-60. doi: 10.1002/(sici)1098-2264(199707)19:3<156::aid-gcc4>3.0.co;2-x.
Zotero 插件